• No results found

Use of biomarkers in the context of orphan medicines designation in the European Union

N/A
N/A
Info
Download
Protected

Academic year: 2020

Share "Use of biomarkers in the context of orphan medicines designation in the European Union"

Copied!
6
0
0

Loading.... (view fulltext now)

Download now ( 6 Page )

Full text

Loading

Figure

Table 1 Glossary used in this paper
Table 2 General requirements and special considerations for the description of the condition in an application fororphan designation reproduced from the guideline ENTR 6283/00 Rev 03

References

Download now ( PDF - 6 Page - 278.47 KB )

Related documents